VIVO Cannabis (TSXV: VIVO) (OTCQX: VVCIF) - Investor Dashboard

➔ VIVO Cannabis
Sector: Healthcare
Industry: Legal Cannabis
Country: Canada
Employees: 133 at 12/31/18
Established: 2012
CEO: Barry Fishman


Fiscal Year-End: December
Facilities: 3
Dried Flower: Production and Sale
Extracts: Production and Sale
Number of Patients: N/A
Headquarters: Napanee, Ontario

Financials (03/31/19)

Cash on hand: $68.4mm
Fixed Investment: $37.2mm
Shareholders’ Equity: $228.7mm
Revenues – Last Quarter: $5.1mm
Adj. Gross Margin : 30.1%
EPS : 0.02

Capital Structure (05/28/18)

Last Financing: 11.5mm Units at $3.50
Basic Shares: 295.2mm
Warrants: 15.0mm
Options: 10.1mm
Diluted Shares: 333.7mm

Company Brief

VIVO Cannabis Inc (TSXV: VIVO) (OTCQX: VVCIF) is a vertically integrated cannabis business focused on providing products and services that help people live better lives. VIVO participates in both the medical and adult-use markets with premium brands tailored to specific consumer segments and needs including Beacon MedicalTM, FIRESIDE CannabisTM, and LUMINA WellnessTM. VIVO also acquired 100% ownership of Canna FarmsTM – BC’s first and highly acclaimed licensed cannabis producer. In addition, VIVO owns Harvest Medicine, one of Canada’s fastest growing medical cannabis clinics. With a commitment to quality and innovation – and a strong cash position – VIVO is well-positioned to be a respected cannabis company in Canada and select international markets.

Featured Video




  • Focus on pharmaceutical grade plant standardization
  • 94.7% customer retention rate
  • Organic production using exclusive, computer-controlled environmental system
  • Annual funded capacity of 57,000 kilograms by mid-2020
  • More than $100 million in cash
  • Health and wellness brand Beacon Medical; adult-use brands Lumina and Fire Side

Growth Strategy

  • Expand existing facility and constructing a second facility targeting 40-kilogram per annum production capacity
  • International market focus on Europe and Australia
  • Active discussions to license production to U.S. operators
  • Scale up Harvest Medicine platform
  • 100% acquired licensed producer Canna Farms in British Columbia
  • Telemedicine offering developed by Harvest Medicine
  • Strategic partnerships with access to pharma networks


  • Production through computer-controlled environmental systems
  • Industry-leading efficiency in terms of yield per square foot
  • Research partnerships with University of Guelph, Pharmascience, Loyalist College, and Think Research
  • Investment and supply agreement with the Choom brand
  • Supply agreements with Alberta, Ontario, British Columbia, Manitoba, Saskatchewan, and Yukon
  • Retail partnerships with Choom, Westleaf, and National Access Cannabis
  • Canna Farms online shopping platform with more than 40 cannabis strains and 100 SKUs

Strong Advisory Board Led by
the “Father of Cannabis Medicine”

Raphael-Mechoulam-ABcannDr. Raphael Mechoulam is an Israeli organic chemist and professor of Medicinal Chemistry at the Hebrew University of Jerusalem in Israel. Mechoulam is best known for his work (together with Y. Gaoni) in the isolation, structure elucidation and total synthesis of Δ9-tetrahydrocannabinol, the main active principle of cannabis and for the isolation and the identification of the endogenous cannabinoids anandamide from the brain and 2-arachidonoyl glycerol (2-AG) from peripheral organs together with his students, postdocs and collaborators.

Institutional Analyst Coverage

Pi Financial

Mackie Research

Curated Stories & News

Visit VIVO Cannabis Inc (Formerly known as ABcann Global, Inc.)

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. VIVO Cannabis Inc (Formerly known as ABcann Global, Inc.) is a client of NCV Media, LLC. Read our full disclaimer.